High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Size: Market Cap wise it is among the top 20% companies of india.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Technicals: Bullish SharesGuru indicator.
Balance Sheet: Strong Balance Sheet.
Momentum: Stock has a weak negative price momentum.
Past Returns: Underperforming stock! In past three years, the stock has provided -3.7% return compared to 8.9% by NIFTY 50.
Growth: Poor revenue growth. Revenue grew at a disappointing -5% on a trailing 12-month basis.
Valuation | |
|---|---|
| Market Cap | 23.73 kCr |
| Price/Earnings (Trailing) | 43.1 |
| Price/Sales (Trailing) | 2.99 |
| EV/EBITDA | 24.34 |
| Price/Free Cashflow | -36.75 |
| MarketCap/EBT | 31.34 |
| Enterprise Value | 25.01 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 7.95 kCr |
| Rev. Growth (Yr) | -3.4% |
| Earnings (TTM) | 550.65 Cr |
| Earnings Growth (Yr) | 8.6% |
Profitability | |
|---|---|
| Operating Margin | 10% |
| EBT Margin | 10% |
| Return on Equity | 9.38% |
| Return on Assets | 6.34% |
| Free Cashflow Yield | -2.72% |
Growth & Returns | |
|---|---|
| Price Change 1W | -4.7% |
| Price Change 1M | -0.30% |
| Price Change 6M | 2.8% |
| Price Change 1Y | -16% |
| 3Y Cumulative Return | -3.7% |
| 5Y Cumulative Return | -0.20% |
| 7Y Cumulative Return | 28.9% |
| 10Y Cumulative Return | 35.6% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | -668.65 Cr |
| Cash Flow from Operations (TTM) | 538.95 Cr |
| Cash Flow from Financing (TTM) | 193.35 Cr |
| Cash & Equivalents | 243.14 Cr |
| Free Cash Flow (TTM) | -645.71 Cr |
| Free Cash Flow/Share (TTM) | -47.34 |
Balance Sheet | |
|---|---|
| Total Assets | 8.68 kCr |
| Total Liabilities | 2.81 kCr |
| Shareholder Equity | 5.87 kCr |
| Current Assets | 3.07 kCr |
| Current Liabilities | 1.28 kCr |
| Net PPE | 3.21 kCr |
| Inventory | 862.3 Cr |
| Goodwill | 2.66 Cr |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.18 |
| Debt/Equity | 0.26 |
| Interest Coverage | 15.45 |
| Interest/Cashflow Ops | 12.71 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 7.5 |
| Dividend Yield | 0.46% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
Size: Market Cap wise it is among the top 20% companies of india.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Technicals: Bullish SharesGuru indicator.
Balance Sheet: Strong Balance Sheet.
Momentum: Stock has a weak negative price momentum.
Past Returns: Underperforming stock! In past three years, the stock has provided -3.7% return compared to 8.9% by NIFTY 50.
Growth: Poor revenue growth. Revenue grew at a disappointing -5% on a trailing 12-month basis.
Investor Care | |
|---|---|
| Dividend Yield | 0.46% |
| Dividend/Share (TTM) | 7.5 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 40.37 |
Financial Health | |
|---|---|
| Current Ratio | 2.4 |
| Debt/Equity | 0.26 |
Technical Indicators | |
|---|---|
| RSI (14d) | 48.54 |
| RSI (5d) | 31.78 |
| RSI (21d) | 49.49 |
| MACD Signal | Sell |
| Stochastic Oscillator Signal | Hold |
| SharesGuru Signal | Buy |
| RSI Signal | Hold |
| RSI5 Signal | Hold |
| RSI21 Signal | Hold |
| SMA 5 Signal | Sell |
| SMA 10 Signal | Sell |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Buy |
| SMA 100 Signal | Buy |
Summary of Deepak Nitrite's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
In the Q4 & FY26 earnings call, Deepak Nitrite management expressed optimism about the company's operational and strategic performance despite a challenging global environment. For Q4 FY26, the consolidated revenues reached INR 2,127 crore, up from INR 1,983 crore in Q3, while EBITDA was reported at INR 383 crore, reflecting a sequential growth of 74%. Notably, profit after tax (PAT) surged to INR 220 crore, representing a 120% increase quarter-on-quarter. The EBITDA margin improved significantly to 18%, up from 11% in the previous quarter.
For the full fiscal year FY26, consolidated revenue amounted to INR 7,947 crore, with EBITDA at INR 1,041 crore and PAT at INR 551 crore. Management reiterated strong growth prospects driven by robust domestic demand in sectors such as automotive, pharmaceuticals, and infrastructure.
Looking ahead, the company anticipates continued volatility due to geopolitical factors, but plans to focus on expanding its value-added product portfolio and enhancing geographically diverse supply chains. Key upcoming projects include the commissioning of agrochemical intermediates and MIBK, MIBC products in Q2 FY27, and the polycarbonate facility set for completion in June 2028, with an investment of approximately INR 11,000 crore funded through a 60:40 debt-equity ratio.
Management highlighted that ongoing cost optimization initiatives and enhanced operational efficiencies will support margin improvements, positing that FY27 will see better performance compared to FY26. They are also actively engaging with customers to maintain competitive positioning despite market fluctuations.
Sanjesh Jain (ICICI Securities): First, on the nitric acid, can you just help us understand in this quarter, what was the utilization? Did we achieve the margin profile we were looking at?
Maulik Mehta (Deputy Managing Director): In Q4, we started the plant but faced technical issues, limiting utilization to about 45%. We are addressing these concerns with our suppliers. Once the plant stabilizes, we expect to reach our target of an additional INR 90 crore to INR 100 crore in EBITDA from nitric acid.
Sanjesh Jain: On the Phenolics side, on the raw material availability of propylene, are we able to run the plant at full capacity?
Maulik Mehta: In Q1, we expect productivity and efficiencies to continue improving compared to Q4. We have secured sufficient feedstock to maintain operations and do not foresee challenges with propylene availability. Our profitability should also remain healthy.
Nirav Jimudia (Anvil Wealth): Regarding the fluorinated molecule project and new products, how do you see FY27?
Maulik Mehta: We anticipate regular commercial production of our new products from Q3 FY27, with positive customer feedback on the validation batches. We've also secured raw materials preemptively, allowing us to maintain stable operations and supply.
Tushar Raghatate: The increase in receivable days"”what's the reason?
Sanjay Upadhyay (CFO): The increase is due to a change in our model to reduce risk amid volatility. We are now using a dealership model, which secures outstanding amounts better. The realization has decreased compared to historical numbers, but we maintain full capacity.
Rohit Nagraj (360 ONE Capital): Are we operating at optimal utilization of the Phenolic plant after maintenance?
Maulik Mehta: The maintenance was brief, and we are currently operating at high efficiencies. We do not anticipate constraints from either plant operations or feedstock availability moving forward.
Archit Joshi (Nuvama IE): In terms of nitration, are we ramping up well?
Maulik Mehta: Both nitration and hydrogenation plants are operational at optimal productivity levels. The nitric acid plant had encountered technical challenges but is on track for recovery.
Vidhi Shah (C.R. Kothari & Sons): When do we expect to commission the polycarbonate project and its funding source?
Maulik Mehta: We expect to commission the polycarbonate project by June 2028. The funding is structured at a 60-40 debt-equity ratio, with necessary bank loans already secured. We generate enough cash to meet our funding needs.
Analysis of Deepak Nitrite's financial performance, highlighting revenue trends, growth patterns, and key metrics through quarterly analysis.
Last Updated: Mar 31, 2026
| Description | Share | Value |
|---|---|---|
| Phenolics | 66.9% | 1.4 kCr |
| Advanced Intermediates | 33.1% | 707.7 Cr |
| Total | 2.1 kCr |
Understand Deepak Nitrite ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| Deepak Chimanlal Mehta | 16.56% |
| Life Insurance Corporation Of India | 9.47% |
| Stiffen Credits And Capital Pvt Ltd | 6.19% |
| Checkpoint Credits And Capital Pvt Ltd | 5.28% |
| Stepup Credits And Capital Pvt Ltd | 5.08% |
| Stigma Credits And Capital P Ltd | 4.54% |
| Deepak Novochem Technologies Limited | 3.41% |
| Kotak Midcap Fund | 3.23% |
| Skyrose Finvest Pvt Ltd | 2.81% |
| Franklin India Small Cap Fund | 2.63% |
| Pranawa Leafin Pvt Ltd | 1.69% |
| Forex Leafin Pvt Ltd | 1.59% |
| Icici Prudential Multicap Fund | 1.13% |
| Storewell Credits And Capital Private Ltd | 0.65% |
| Sundown Finvest Pvt Ltd | 0.61% |
| Ila Deepak Mehta | 0.44% |
| Hardik Leafin Pvt Ltd | 0.25% |
| Maulik Deepak Mehta | 0.1% |
| Prahaan Maulik Mehta | 0.03% |
| Aadya Meghav Mehta | 0.03% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of Deepak Nitrite against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| SRF | SRF | 78.24 kCr | 15.89 kCr | +5.90% | -9.20% | 42.63 | 4.92 | - | - |
| ALKEM | Alkem Lab | 64.62 kCr | 14.78 kCr | -4.00% | +2.00% | 27.25 | 4.37 | - | - |
| ATUL | Atul | 20.71 kCr | 6.48 kCr | +5.50% | -2.30% | 30.55 | 3.2 | - | - |
| AARTIIND | Aarti Industries | 17.27 kCr | 8.31 kCr | +1.20% | +1.60% | 41.19 | 2.08 | - | - |
| VINATIORGA | Vinati Organics | 13.67 kCr | 2.28 kCr | +0.40% | -29.50% | 30.8 | 6 | - | - |
| ALKYLAMINE | Alkyl Amines Chemicals | 8.8 kCr | 1.57 kCr | +15.30% | -3.30% | 48.86 | 5.61 | - | - |
| BALAMINES | Balaji Amines | 5.91 kCr | 1.45 kCr | +49.00% | +27.30% | 35.13 | 4.06 | - | - |
Comprehensive comparison against sector averages
DEEPAKNTR metrics compared to Chemicals
| Category | DEEPAKNTR | Chemicals |
|---|---|---|
| PE | 43.10 | 44.27 |
| PS | 2.99 | 4.18 |
| Growth | -5 % | 7.4 % |
Deepak Nitrite is a Specialty Chemicals company based in India, with the stock ticker DEEPAKNTR. The company has a market capitalization of Rs. 26,978.5 Crores.
It specializes in the manufacturing, trading, and sale of chemical intermediates both domestically and internationally. Deepak Nitrite operates through two segments: Advanced Intermediates and Phenolics.
The product portfolio includes a wide range of chemicals such as:
These products cater to various industries including colourants, dyes, rubber, paper, agrochemicals, pharmaceuticals, personal care, water treatment, glass, explosives, and textiles.
Furthermore, Deepak Nitrite provides essential chemicals like:
These are applied in areas such as laminate and plywood, automotive, construction, pharmaceuticals, adhesives, sanitizers, rubber, chemicals, and paints.
The company also offers various specialty products and services, including project engineering, procurement, construction, commissioning, management, and consultancy services.
Incorporated in 1970 and headquartered in Vadodara, India, Deepak Nitrite has demonstrated strong performance with a trailing 12 months revenue of Rs. 8,308.7 Crores. It also distributes dividends to its investors with a yield of 0.34% per year, having returned Rs. 7.5 dividend per share in the last 12 months. The company has achieved 29% revenue growth over the past three years.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
DEEPAKNTR vs Chemicals (2021 - 2026)